Co-existence of craniopharyngioma and acromegaly has been very rarely reported. A 65-year-old man presented with visual deterioration, fatigue and frontal headaches. Magnetic resonance imaging revealed a suprasellar heterogeneous, mainly cystic, 1.9 × 2 × 1.9 cm mass compressing the optic chiasm and expanding to the third ventricle; the findings were consistent with a craniopharyngioma. Pituitary hormone profile showed hypogonadotropic hypogonadism, mildly elevated prolactin, increased insulin-like growth factor 1 (IGF-1) and normal thyroid function and cortisol reserve. The patient had transsphenoidal surgery and pathology of the specimen was diagnostic of adamantinomatous craniopharyngioma. Post-operatively, he had diabetes insipidus, hypogonadotropic hypogonadism and adrenocorticotropic hormone and thyroid-stimulating hormone deficiency. Despite the hypopituitarism, his IGF-1 levels remained elevated and subsequent oral glucose tolerance test did not show complete growth hormone (GH) suppression. Further review of the pre-operative imaging revealed a 12 × 4 mm pituitary adenoma close to the right carotid artery and no signs of pituitary hyperplasia. At that time, he was also diagnosed with squamous cell carcinoma of the left upper lung lobe finally managed with radical radiotherapy. Treatment with long-acting somatostatin analogue was initiated leading to biochemical control of the acromegaly. Latest imaging has shown no evidence of craniopharyngioma regrowth and stable adenoma. This is a unique case report of co-existence of craniopharyngioma, acromegaly and squamous lung cell carcinoma that highlights diagnostic and management challenges. Potential effects of the GH hypersecretion on the co-existent tumours of this patient are also briefly discussed.
Learning points: Although an extremely rare clinical scenario, craniopharyngioma and acromegaly can co-exist; aetiopathogenic link between these two conditions is unlikely.Meticulous review of unexpected biochemical findings is vital for correct diagnosis of dual pituitary pathology.The potential adverse impact of GH excess due to acromegaly in a patient with craniopharyngioma (and other neoplasm) mandates adequate biochemical control of the GH hypersecretion.
Keywords: 2018; ACTH; Acromegaly; Adult; Breathing difficulties; CT scan; Craniopharyngioma; Desmopressin; Diabetes insipidus; Face - coarse features; Fatigue; Fine needle aspiration biopsy; GH; GH suppression; Glucocorticoids; Glucose tolerance (oral); Gonadotrophins; Gonadotropins; Hands - enlargement; Headache; Histopathology; Hydrocortisone; Hypergonadotropic hypogonadism; Hypogonadism; IGF1; Immunohistochemistry; Lanreotide; Levothyroxine; MRI; Male; March; Oncology; PET scan; Pituitary; Pituitary adenoma; Prolactin; Radiotherapy; Resection of tumour; Somatostatin analogues; Synaptophysin; TSH; Testosterone; Transsphenoidal surgery; Unique/unexpected symptoms or presentations of a disease; United Kingdom; Vision - acuity reduction; Visual field assessment; Visual impairment; White; X-ray.